Emergence of Clostridium difficile NAP1 in Latin America.
Quesada-Gómez
Carlos
C
Rodríguez
César
C
Gamboa-Coronado
María del Mar
Mdel M
Rodríguez-Cavallini
Evelyn
E
Du
Tim
T
Mulvey
Michael R
MR
Villalobos-Zúñiga
Manuel
M
Boza-Cordero
Ricardo
R
D000900:Anti-Bacterial Agents / Q000009:adverse effects* / Q000494:pharmacology; D001427:Bacterial Toxins / Q000235:genetics; D015373:Bacterial Typing Techniques; D016360:Clostridioides difficile / Q000145:classification* / Q000235:genetics / Q000302:isolation & purification*; D016000:Cluster Analysis; D003364:Costa Rica; D003428:Cross Infection / Q000382:microbiology*; D016172:DNA Fingerprinting; D016521:Electrophoresis, Gel, Pulsed-Field; D004761:Enterocolitis, Pseudomembranous / Q000382:microbiology*; D005243:Feces / Q000382:microbiology; D005838:Genotype; D006761:Hospitals; D006801:Humans; D008826:Microbial Sensitivity Tests; D017720:Molecular Epidemiology
D000900:Anti-Bacterial Agents; D001427:Bacterial Toxins